Which hedge funds own ZBIO? ZENAS BIOPHARMA INC, Q2 2026 13F holders
6 of the hedge funds tracked by WhaleCreep disclosed a position in ZBIO (ZENAS BIOPHARMA INC) in their Q2 2026 13F filings, worth $45.7m in total. The largest holder by portfolio weight is Woodline Partners at 0.0% of its book. 2 managers opened a new position this quarter: Brevan Howard Capital Management, Point72 Asset Management LP.
6tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold ZBIO? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Woodline Partners | Q2 2026 | 0.0% | $15.0m | 590,539 | 0% | held |
| Millennium Management | Q2 2026 | 0.0% | $16.8m | 660,470 | 39% | added |
| Marshall Wace | Q2 2026 | 0.0% | $8.2m | 323,442 | -36% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $372.4k | 14,674 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $5.0m | 195,780 | 193% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $409.5k | 16,136 | – | new |
How has hedge fund ownership of ZBIO changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $45.7m |
| Q1 2026 | 4 | $32.0m |
| Q4 2025 | 1 | $9.2m |
| Q4 2024 | 1 | $314.5k |
| Q3 2024 | 2 | $1.6m |
Counts every tracked manager that disclosed ZBIO in that quarter's filing, including managers that have since stopped filing.